P. Kinney

Hematopoietic Protection by Dexamethasone or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients Treated With Carboplatin and Ifosfamide

J. Rinehart, G. Cloud, L. Keville, 2003, American journal of clinical oncology.

Results from phase II trial of enzastaurin (LY317615) in patients with recurrent high grade gliomas

H. Fine, P. Albert, D. Draper, 2005 .

Phase II trial of interferon-beta-serine in metastatic renal cell carcinoma.

J. Drago, P. Triozzi, J. Rinehart, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Central Nervous System Toxicity of Biological Response Modifiers

P. Triozzi, J. Rinehart, P. Kinney, 1990, Annals of the New York Academy of Sciences.

Biologic effects of the adoptive transfer of cells depleted of monocytes with L-phenylalanine methyl ester.

P. Triozzi, J. Rinehart, P. Kinney, 1994, Immunopharmacology.

Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production.

J. Rinehart, M. Wewers, D. Herzyk, 1990, The American journal of physiology.

Lack of significant changes in nutrition-related parameters with tumor necrosis factor treatment of cancer.

R. R. Rice, J. Rinehart, P. Kinney, 1993, Nutrition and cancer.